Vanguard Fiduciary Trust
NUVB icon

Vanguard Fiduciary Trust’s Nuvation Bio NUVB Stock Holding History

Vanguard Fiduciary Trust’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.1M Buy
1,776,554
+184,105
+12% +$900K ﹤0.01% 1805
2026
Q1 		$6.83M Buy
+1,592,449
New +$8.87M ﹤0.01% 1915

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Fiduciary Trust's NUVB Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Nuvation Bio (NUVB) stake by 12% in Q2 2026, buying an estimated $900K and bringing the position to 1,776,554 shares worth $10.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1805.

Vanguard Fiduciary Trust first reported a position in NUVB in Q1 2026 and has held it in 2 quarters since. 242 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Vanguard Fiduciary Trust held 1,776,554 shares of Nuvation Bio worth $10.1M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 184,105 Nuvation Bio shares in Q2 2026, an estimated $900K.
  • Nuvation Bio made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #1805 holding.
  • Vanguard Fiduciary Trust first reported a position in Nuvation Bio in Q1 2026 and has held it in 2 quarters since.
  • 242 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.